From Our Partners
Monday, July 4, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Public Health

Attributes and Predictors of Long-COVID

by Global Biodefense Staff
October 24, 2020
Attributes and Predictors of Long-COVID

Photo by TamWai / Unsplash

Long-COVID is characterized by symptoms of fatigue, headache, dyspnoea and anosmia. At the population level, it is critical to quantify the burden of Long-COVID to better assess its impact on the healthcare system and appropriately distribute resources.

A new study led by researchers from King’s College London suggests Long-COVID affects around 10% of 18-to 49-year-olds following infection with SARS-CoV-2. The study found the syndrome was more likely with increasing age, body mass index (BMI) and female sex.

The scientists analyzed data from 4182 incident cases of self-logged symptoms in the COVID Symptom Study app.

The researchers also found that experiencing more than five symptoms during the first week of illness was associated with Long-COVID.

The method underscored in the study could help determine at-risk groups and could be used to target early intervention trials of treatment and and clinical service developments to support rehabilitation to alleviate Long-COVID.

This paper is a medRxiv pre-print still undergoing peer-review

Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. October 21, 2020. https://doi.org/10.1101/2020.10.19.20214494

From Our Partners
Tags: COVID-19Editor PickEpidemiologyMedicine-HealthSARS-CoV-2

Related Posts

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps
Outbreak News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
Politics and Pandemic Fatigue Doom California’s Covid Vaccine Mandates
Public Health

Politics and Pandemic Fatigue Doom California’s Covid Vaccine Mandates

May 31, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC